These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39136523)

  • 1. Ruthenium Complex Suppresses Proliferation of Residual Hepatocellular Carcinoma after Incomplete Radiofrequency Ablation Therapy.
    Yu ZJ; Guo SW; Wang BS; Ouyang S; Zhang XH; Zhao ZZ; Wang JQ
    Recent Pat Anticancer Drug Discov; 2024 Aug; ():. PubMed ID: 39136523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
    Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
    BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
    Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
    Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy.
    Zhao Z; Wu J; Liu X; Liang M; Zhou X; Ouyang S; Yao J; Wang J; Luo B
    Cancer Lett; 2018 May; 421():73-81. PubMed ID: 29458142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop.
    Wang X; Deng Q; Feng K; Chen S; Jiang J; Xia F; Ma K; Bie P
    Oncol Rep; 2018 Jul; 40(1):241-251. PubMed ID: 29749472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation.
    Ren Y; Zhu L; Guo Y; Ma J; Yang L; Zheng C; Dong X
    J Pharm Anal; 2024 Aug; 14(8):100942. PubMed ID: 39263355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation.
    Guo Y; Ren Y; Dong X; Kan X; Zheng C
    J Hepatocell Carcinoma; 2022; 9():343-355. PubMed ID: 35502292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
    Liu J; Li X; Chen J; Guo J; Guo H; Zhang X; Fan J; Zhang K; Mao J; Zhou B
    J Nanobiotechnology; 2024 Jun; 22(1):338. PubMed ID: 38890737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
    J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma.
    Tang Y; Shu Z; Zhu M; Li S; Ling Y; Fu Y; Hu Z; Wang J; Yang Z; Liao J; Xu L; Yu M; Peng Z
    Adv Healthc Mater; 2023 Dec; 12(30):e2302013. PubMed ID: 37665720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
    Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
    J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment.
    Ao F; Li X; Tan Y; Jiang Z; Yang F; Guo J; Zhu Q; Chen Z; Zhou B; Zhang K; Li D
    J Control Release; 2024 May; 369():296-308. PubMed ID: 38301925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous inhibition of heat shock proteins and autophagy enhances radiofrequency ablation of hepatocellular carcinoma.
    Zhao J; Lei L; Dai W; Jiang A; Jin Q; Tang Z
    Biomater Sci; 2024 Nov; 12(23):6082-6098. PubMed ID: 39429155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
    Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
    J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly expressed HIF-1α enhances HCC stem cell-like traits via Wnt/β-catenin signaling activation after insufficient radiofrequency ablation.
    Zhang N; Chen R; Cao X; Wang L
    J Cancer Res Ther; 2023 Dec; 19(6):1517-1524. PubMed ID: 38156917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma.
    Wang S; Liu J; Wu H; Jiang A; Zhao K; Yan K; Wu W; Han H; Zhang Y; Yang W
    Chin J Cancer Res; 2021 Dec; 33(6):694-707. PubMed ID: 35125813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
    Liang X; Liu Q; Zhu S; Li Z; Chen H; Su Z
    Transl Oncol; 2024 Jan; 39():101796. PubMed ID: 37862939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
    Zhang Y; Zhang Y; Wang J; Gu H
    Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting PI3Kγ/AKT Pathway Remodels LC3-Associated Phagocytosis Induced Immunosuppression After Radiofrequency Ablation.
    Liu X; Zhang W; Xu Y; Xu X; Jiang Q; Ruan J; Wu Y; Zhou Y; Saw PE; Luo B
    Adv Sci (Weinh); 2022 Mar; 9(7):e2102182. PubMed ID: 35037422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.